Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Retatrutide (development code LY3437943) is an investigational injectable peptide being developed by Eli Lilly and Company
start with the labeled dose and follow guidance from your clinician
If you miss a dose, most protocols suggest taking it as soon as you remember, provided the next scheduled dose is at least 3 days (72 hours) away
Percentage of significant correlations between classes of lipids across phenotypes
Some people may experience mild gastrointestinal symptoms such as nausea, constipation, or abdominal discomfort, especially at the start of treatment
If it stays up, the elevation needs a fuller workup
US$ 23.03
US$ 25.15
US$ 25.19
US$ 26.91
US$ 27.60
US$ 27.89
US$ 20.34
US$ 21.19
US$ 21.72
